These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6770237)

  • 21. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
    Halstead SB; Eckels KH; Putvatana R; Larsen LK; Marchette NJ
    Am J Trop Med Hyg; 1984 Jul; 33(4):679-83. PubMed ID: 6476215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of leukocytes permissive to dengue 2 virus in the acute phase of dengue hemorrhagic fever.
    Marchette NJ; O'Rourke T; Scott RM; Nimmannitya S; Halstead SB; Bancroft WH
    Am J Trop Med Hyg; 1979 May; 28(3):570-6. PubMed ID: 453450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R
    Am J Trop Med Hyg; 1984 Jul; 33(4):666-71. PubMed ID: 6476213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
    J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathogenesis of dengue infection in the rhesus monkey.
    Marchette NJ; Halstead SB
    Transplant Proc; 1974 Jun; 6(2):197-201. PubMed ID: 4208756
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
    Halstead SB
    Rev Infect Dis; 1989; 11 Suppl 4():S830-9. PubMed ID: 2665015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.
    Brandt WE; McCown JM; Top FH; Bancroft WH; Russell PK
    Infect Immun; 1979 Nov; 26(2):534-41. PubMed ID: 121109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease.
    Morens DM; Marchette NJ; Chu MC; Halstead SB
    Am J Trop Med Hyg; 1991 Nov; 45(5):644-51. PubMed ID: 1951875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of dengue virus replication in vitro by rimantadine hydrochloride.
    Koff WC; Elm JL; Halstead SB
    Am J Trop Med Hyg; 1981 Jan; 30(1):184-9. PubMed ID: 7212165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
    Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olive baboons: a non-human primate model for testing dengue virus type 2 replication.
    Valdés I; Gil L; Castro J; Odoyo D; Hitler R; Munene E; Romero Y; Ochola L; Cosme K; Kariuki T; Guillén G; Hermida L
    Int J Infect Dis; 2013 Dec; 17(12):e1176-81. PubMed ID: 24139794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control.
    Fink K; Ng C; Nkenfou C; Vasudevan SG; van Rooijen N; Schul W
    Eur J Immunol; 2009 Oct; 39(10):2809-21. PubMed ID: 19637226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurovirulence detection of dengue virus using rhesus and cynomolgus monkeys.
    Angsubhakorn S; Moe JB; Marchette NJ; Latendresse JR; Palumbo NE; Yoksan S; Bhamarapravati N
    J Virol Methods; 1987 Oct; 18(1):13-24. PubMed ID: 3693516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys.
    Galler R; Marchevsky RS; Caride E; Almeida LF; Yamamura AM; Jabor AV; Motta MC; Bonaldo MC; Coutinho ES; Freire MS
    Braz J Med Biol Res; 2005 Dec; 38(12):1835-46. PubMed ID: 16302098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
    Blaney JE; Matro JM; Murphy BR; Whitehead SS
    J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: a potential model for vaccine testing.
    Martín J; Hermida L; Castro J; Lazo L; Martínez R; Gil L; Romero Y; Puente P; Zaragoza S; Cosme K; Guzmán MG; Cardosa J; Guillén G
    Microbiol Immunol; 2009 Apr; 53(4):216-23. PubMed ID: 19714858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection.
    Halstead SB; Shotwell H; Casals J
    J Infect Dis; 1973 Jul; 128(1):15-22. PubMed ID: 4198024
    [No Abstract]   [Full Text] [Related]  

  • 39. Dengue 2 virus enhancement in asthmatic and non asthmatic individual.
    Guzman MG; Kouri G; Soler M; Bravo J; Rodríguez de La Vega A; Vazquez S; Mune M
    Mem Inst Oswaldo Cruz; 1992; 87(4):559-64. PubMed ID: 1343671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.
    Blaney JE; Sathe NS; Goddard L; Hanson CT; Romero TA; Hanley KA; Murphy BR; Whitehead SS
    Vaccine; 2008 Feb; 26(6):817-28. PubMed ID: 18191005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.